Analysts/Institutional Investor Meet/Con. Call Updates

INDIA PESTICIDES LIMITED An ISO 9001:2015, 14001:2015, 45001:2018 and 10002:2018 Company CIN No. L24112 UP1984PLC006894 GSTIN- 09AAACI3591D1ZO IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLLIPLIPL IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPLIPLIPLIPLIPL Water Works Road, Aishbagh, Lucknow – 226004 (INDIA) Tel: +91-522-2653602, 2653603, 2653622, 4041014 Fax: +91-522-2653610 Website: www.indiapesticideslimited.com E-mail: info@indiapesticideslimited.com Date: 10.11.2026 To To The Manager, The Manager, Listing Department Listing & Compliance Department BSE Limited National Stock Exchange of India Ltd. P. J. Towers, Dalal Street, Mumbai-400001 Exchange Plaza, Plot no. C/1, G Block, Scrip Code: 543311 Bandra- Kurla Complex, Mumbai-400051 ISIN: INE0D6701023 Symbol: IPL Dear Sir/ Ma'am, Sub: Transcript of the Earnings Call for the quarter and half-year ended 30th September, 2026. Pursuant to Regulation 30(6) read with Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby enclose the transcript of the Analyst/Investors Call held on Thursday, 05th November, 2026 at 12:30 P.M, in respect of the Un-audited Standalone and Consolidated Financial Results of the Company for the quarter and half-year ended 30th September, 2026. The transcript of the earnings call is also available on the Company’s website at www.indiapesticideslimited.com Kindly take the above on your record. Thanking you Yours faithfully, For India Pesticides Limited (Narendra Ojha) Company Secretary and Compliance Officer Encl.: As Above IPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIPLIIPLIPLIPLIPL Regd. Office: Swarup Bhawan, 35-A, Civil Lines, Bareilly – 243 001. Uttar Pradesh, India. Phone: 0581-2567476 Manufacturing Unit 1: Plot No: E-17 to E-23 & G-31 to G-35, UPSIDC Industrial Area, Dewa Road, Chinhat, Lucknow, (UP) Manufacturing Unit 2: Plot No: K-2 to K-12 & D-2 to D-4, UPSIDC Industrial Area, Sandila, Hardoi, (UP) “India Pesticides Limited Q2 and H1 FY27 Earnings Conference Call” November 05, 2026 MANAGEMENT: MR. D. K. JAIN – CHIEF EXECUTIVE OFFICER MR. S. P. GUPTA – CHIEF FINANCIAL OFFICER MODERATOR: MS. SAVITA SINGH – DOLAT CAPITAL Page 1 of 12 India Pesticides Limited November 05, 2026 Moderator: Ladies and gentlemen, good day, and welcome to the India Pesticides Q2 and H1 FY27 Earnings Conference Call. As a reminder, all participant lines will be in the listen-only mode and there will be an opportunity for you to ask questions after the presentation concludes. Should you need assistance during the conference call, please signal an operator by pressing star then zero on your touchtone phone. Please note that this conference is being recorded. I now hand the conference over to Ms. Savita Singh from Dolat Capital. Thank you, and over to you, ma'am. Savita Singh: Thank you, Shruti. Good day, everyone. I'm Savita Singh on behalf of Dolat Capital, welcome you all to the Q2 FY27 Earnings Conference Call of India Pesticides Limited. I would like to thank the management for giving us this opportunity to host the call. Today from the management team, we have with us Mr. D.K. Jain, CEO; and Mr. S.P. Gupta, CFO. I now hand over the call to the management for their opening remarks. Over to you, sir. D.K. Jain: Thank you, Savita ji. Good afternoon, ladies and gentlemen. I take pleasure in welcoming you all to the Q2 and H1 FY27 Earnings Conference Call of India Pesticides Limited. I hope you and your families are doing well. I trust you have had the opportunity to review our financial statements and earnings presentation uploaded on the stock exchanges and on our website. The second quarter remained challenging for the agrochemical industry with geopolitical uncertainty, softer overseas demand and volatility in key raw material prices affecting business conditions. In India, deficient and erratic rainfall disrupted agricultural activity and reduced herbicide application. Against this backdrop, we remain focused on managing costs, maintaining manufacturing efficiency and advancing the initiatives supporting our long term growth. From a business perspective, monsoon stress across Maharashtra, Andhra Pradesh, Karnataka, Telangana and parts of Punjab and Haryana affected paddy and other Kharif crops. Overseas demand for our herbicide also remains softer with export revenue of INR 177 crores during H1 FY27. Encouragingly, we have received export orders for the coming quarter, providing support to our near term business outlook. We continue to serve customers across more than 35 countries, supported by long-standing relationship with over 60 international customers, including multinational agrochemical companies. Our ability to manufacture complex off-patent technologies to demanding quality specifications remains central to these relationships. We are focused on broadening our customer base and strengthening direct engagement with global formulators. An important development during the quarter was the receipt of technical equivalence approval for one of our insecticide products in United Kingdom and registration of one of our herbicide product in Argentina. Page 2 of 12 India Pesticides Limited November 05, 2026 These approvals advance our international expansion strategy and create opportunities to commercialize products in additional markets. They also reflect our manufacturing quality and regulatory capabilities. Building on the European Union approval received in the previous quarter, we will continue to pursue registrations that widen market access and support a more diversified export portfolio. Our manufacturing platform remains an important pillar of our growth strategy. Across Dewa Road and Sandila, our installed capacity of 28,300 metric tons of technicals and 10,200 metric tons of formulations. Our focus is on using the infrastructure efficiently while developing capacity for new products and future customer requirement. At Hamirpur, 2 of the 10 planned blocks are operational and 2 additional blocks are expected to become operational early next year. Central infrastructure, including roads, boilers and chillers are already in place. With permitted capacity of 30,000 metric tons of technicals and 6,000 metric tons of formulations, the facility provides a clear pathway for phased expansion. And considering the overall geopolitical situation, we need to revisit the product portfolio of our plant at Hamirpur plant. Backward integration remains a key priority. Our intermediate plant developed using indigenous in-house R&D technology supports the manufacture of intermediate previously sourced through imports. Expanding these capabilities will help improve supply reliability and cost competitiveness, particularly as geopolitical developments continue to create uncertainty across global supply chains. Research and development continues to guide our product and manufacturing strategy. Our 2 DSIR recognized R&D centers supported by a team of 25 scientists focused on developing new molecules and intermediates, improving product yields and optimizing raw material consumption. This work supports both our existing portfolio and opportunities in [Showing first 8,000 characters — download PDF for full document]